Cresco Labs (CRLBF) Retained Earnings (2019 - 2026)
Cresco Labs' (CRLBF) quarterly Retained Earnings came in at -$1.8 million in Q1 2026, up 17.52% YoY from -$1.6 million in Q1 2025, and down 12.26% on a QoQ basis from -$1.6 million in Q4 2025.
Cresco Labs (CRLBF) Retained Earnings (2019 - 2026) Analysis & Trends
Cresco Labs (CRLBF) has 8 years of Retained Earnings data on file, last reported at -$1.8 million in Q1 2026.
- Quarterly Retained Earnings rose 17.52% year-over-year to -$1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.8 million (up 17.52% YoY) and the FY2025 annual result came in at -$1.6 million, up 26.93% from the prior year.
- Retained Earnings eased to -$1.8 million in Q1 2026, from -$1.6 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $82.9 million in Q4 2023 to a low of -$2.2 million in Q4 2024.
- A 5-year average of $3.6 million and a median of -$1.4 million in 2024 frame the typical range for Retained Earnings.
- The widest YoY moves for Retained Earnings: up 6053.12% in 2023, down 471.97% in 2023.
- Tracing CRLBF's Retained Earnings over 5 years: stood at -$1.4 million in 2022, then soared by 6053.12% to $82.9 million in 2023, then slumped by 102.69% to -$2.2 million in 2024, then gained by 26.93% to -$1.6 million in 2025, then decreased by 12.26% to -$1.8 million in 2026.
- The last three Retained Earnings figures came in at -$1.8 million (Q1 2026), -$1.6 million (Q4 2025), and -$1.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 3.75 Bn |
| 10 | Cresco Labs | 290.46 Mn | 226.34 Mn | 86.95 Mn | -1.50 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.83 Mn |
| Dec 31, 2025 | -1.63 Mn |
| Sep 30, 2025 | -1.82 Mn |
| Jun 30, 2025 | -1.59 Mn |
| Mar 31, 2025 | -2.22 Mn |
| Dec 31, 2024 | -2.23 Mn |
| Sep 30, 2024 | -1.43 Mn |
| Jun 30, 2024 | -1.60 Mn |
| Mar 31, 2024 | -1.46 Mn |
| Dec 31, 2023 | 82.93 Mn |
| Sep 30, 2023 | -1.37 Mn |
| Jun 30, 2023 | -1.16 Mn |
| Mar 31, 2023 | -1.39 Mn |
| Dec 31, 2022 | -1.39 Mn |
| Sep 30, 2022 | -239,000.00 |
| Jun 30, 2022 | -428,000.00 |
| Mar 31, 2022 | -444,000.00 |
| Dec 31, 2021 | -841.91 Mn |
| Sep 30, 2021 | -362,000.00 |
| Mar 31, 2021 | -293,000.00 |